FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--MEDNAX, Inc., (NYSE: MD) today announced that it is scheduled to make a presentation on Thursday, December 13, 2012 at 10:35 a.m. EST to investors attending the 23rd Annual Oppenheimer Healthcare Conference in New York City.
The presentation by MEDNAX’s Chief Financial Officer, Vivian Lopez-Blanco, will be broadcast through a live audio webcast and will be available for replay at www.mednax.com/investors.
MEDNAX, Inc. is a national medical group that comprises the nation's leading provider of neonatal, maternal-fetal and pediatric physician subspecialty services as well as anesthesia services. Physicians and advanced practitioners practicing as part of MEDNAX are reshaping the delivery of care within their specialties and subspecialties, using evidence-based tools, continuous quality initiatives and clinical research to enhance patient outcomes and provide high-quality, cost-effective care. Pediatrix Medical Group, a unit of MEDNAX, was founded in 1979 and now includes neonatal physicians who provide services at more than 300 neonatal intensive care units, who collaborate with affiliated maternal-fetal medicine, pediatric cardiology and pediatric critical care physician subspecialists to provide a clinical care continuum. Pediatrix is also the nation's largest provider of newborn hearing screens. In 2007, MEDNAX expanded into anesthesia services. Today, American Anesthesiology includes more than 1,250 anesthesiologists and advanced practitioners who provide anesthesia care to patients in connection with surgical and other procedures as well as pain management. MEDNAX, through its affiliated professional corporations, employs more than 1,925 physicians in 34 states and Puerto Rico. Additional information is available at www.mednax.com.